Additional Metadata
Keywords decitabine, cytarabine, acute myeloid leukaemia, DNA methylation, ESR1, CDKN2B
Persistent URL dx.doi.org/10.1111/bjh.15847, hdl.handle.net/1765/119439
Journal British Journal of Haematology
Citation
Kearns, P, Zwaan, C.M, Reinhardt, D, Gibson, B., Moreno, L, Nysom, K., … Nemat, S. (2019). Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. British Journal of Haematology, 186(3), E7–E11. doi:10.1111/bjh.15847